Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells
Jana Koch, Zina M. Uckeley, Patricio Doldan, et al.
The EMBO Journal (2021) Vol. 40, Iss. 16
Open Access | Times Cited: 292

Showing 1-25 of 292 citing articles:

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 693-699
Open Access | Times Cited: 618
Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 420
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, et al.
The EMBO Journal (2021) Vol. 40, Iss. 24
Open Access | Times Cited: 172
In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
Agnieszka M. Szemiel, Andres Merits, Richard Orton, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009929-e1009929
Open Access | Times Cited: 141
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
Rachid Essalmani, Jaspreet Jain, Delia Susan‐Resiga, et al.
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 134
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
Delphine Planas, Isabelle Staropoli, Vincent Michel, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 129
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants
Panke Qu, Kai Xu, Julia N. Faraone, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 585-595.e6
Open Access | Times Cited: 105
Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs
Antoine Rebendenne, Priyanka Roy, Boris Bonaventure, et al.
Nature Genetics (2022) Vol. 54, Iss. 8, pp. 1090-1102
Open Access | Times Cited: 99
Tunneling nanotubes provide a route for SARS-CoV-2 spreading
Anna Pepe, Stefano Pietropaoli, Matthijn Vos, et al.
Science Advances (2022) Vol. 8, Iss. 29
Open Access | Times Cited: 98
SARS-CoV-2 spike protein–induced cell fusion activates the cGAS-STING pathway and the interferon response
Xiaoman Liu, Wei Liang, Fengwen Xu, et al.
Science Signaling (2022) Vol. 15, Iss. 729
Closed Access | Times Cited: 91
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 82
SARS-CoV-2 and the Host Cell: A Tale of Interactions
Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, et al.
Frontiers in Virology (2022) Vol. 1
Open Access | Times Cited: 72
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
Bingjie Hu, Jasper Fuk‐Woo Chan, Huan Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2275-2287
Open Access | Times Cited: 72
SARS‐CoV‐2 infection and multi-organ system damage: a review
Ali A. Rabaan, Samira Smajlović, Hüseyin Tombuloğlu, et al.
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 70
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 67
TMPRSS2 is a functional receptor for human coronavirus HKU1
Nell Saunders, I. Fernández, Cyril Planchais, et al.
Nature (2023) Vol. 624, Iss. 7990, pp. 207-214
Open Access | Times Cited: 60
Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants
Cun Li, Jingjing Huang, Yifei Yu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 17
Open Access | Times Cited: 47
Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants
Panke Qu, Kai Xu, Julia N. Faraone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 46
Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19
Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Med (2024) Vol. 5, Iss. 1, pp. 42-61.e23
Open Access | Times Cited: 20
Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating
Nikhila S. Tanneti, Anant K. Patel, Li Tan, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 20
Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
Guoli Shi, Tiansheng Li, Kin Kui Lai, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
A coronavirus assembly inhibitor that targets the viral membrane protein
Manon Laporte, Dirk Jochmans, Dorothée Bardiot, et al.
Nature (2025)
Open Access | Times Cited: 3
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
Matthew Mahoney, Vishnu C. Damalanka, Michael A. Tartell, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 43
Open Access | Times Cited: 96
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús‐González, Carlos Daniel Cordero‐Rivera, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 89
Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L
Anneliese S. Ashhurst, Arthur H. Tang, Pavla Fajtová, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2956-2970
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top